Dr. Christopher Cogle, MD

• Medical Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Duke University Medical Center

  Fellowship Hospital, 2003

• University Of Fl College Of Med

  Residency Hospital, 2000

• University Of Florida

  Fellowship Hospital, 2000

• University Of Florida College Of Medicine

  Internship Hospital, 1998

• University Of Florida College Of Medicine

  Medical School, 1997

• University Of Florida, Gainesville

  Undergraduate School, 1994

• Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial Infarction: The TIME Randomized Trial, 2012-12-12

• Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemia, 2017-11-27

• Endothelial cell derived angiocrine support of acute myeloid leukemia targeted by receptor tyrosine kinase inhibition, 2015-07-02

• Oncolytic Virotherapy for Hematological Malignancies, 2011-10-29

• Incidence and Burden of the Myelodysplastic Syndromes, 2015-07-02

• Ex-vivo Sensitivity Profiling to Guide Clinical Decision Making in Acute Myeloid Leukemia: A Pilot Study, 2017-11-11

• Specialized Proresolving Mediators in Symptomatic Women With Coronary Microvascular Dysfunction (from the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD [WARRIOR] Trial), 2021-10-30

• Acute Myeloid Leukemia Targeting by Myxoma VirusIn VivoDepends on Cell Binding But Not Permissiveness to InfectionIn Vitro, 2012-02-17

• Angiotensin II Regulation of Proliferation, Differentiation and Engraftment of Hematopoietic Stem Cells, 2016-01-18

• Clinical significance of In vivo Cytarabine Induced Gene Expression Signature in AML, 2015-10-16

• Risk, Characteristics and Biomarkers of Cytokine Release Syndrome in Patients with Relapsed/Refractory AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436, 2021-10-21

• Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study, 2016-08-19

• Pharmacokinetics and Pharmacodynamics with Extended Dosing of CC-486 in Patients with Hematologic Malignancies, 2015-08-21

• Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies, 2016-03-22

• Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus, 2010-03-07

• Rationale and Design for TIME: A Phase-II, Randomized, Double-Blind, Placebo-Controlled Pilot Trial Evaluating the Safety and Effect of Timing of Administration of Bone Marrow Mononuclear Cells Following Acute Myocardial Infarction, 2009-07-23

• A Detailed Analysis of Bone Marrow from Patients with Ischemic Heart Disease and Left Ventricular Dysfunction: BM CD34, CD11b and Clonogenic Capacity as Biomarkers for Clinical Outcomes, 2014-08-18

• Integrative Analysis of Drug Response and Clinical Outcome in Acute Myeloid Leukemia, 2022-07-21

• A Phase 1B Clinical Study of Combretastatin A1 Diphosphate (OXi4503) and Cytarabine (ARA-C) in Combination (OXA) for Patients with Relapsed or Refractory Acute Myeloid Leukemia, 2019-12-26

• A Clinical Phase 1B Study of the CD3xCD123 Bispecific Antibody APVO436 in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome, 2021-08-15

• Exploring the structure activity relationship and mechanism of a chromene scaffold (CXL series) for its selective anti-proliferative activity towards multidrug resistant cancer cells, 2018-07-25

• Functional Integration of Acute Myeloid Leukemia into the Vascular Niche, 2014-03-18

• A Critical Analysis of Clinical Outcomes Reported in Stem Cell Trials for Acute Myocardial Infarction: Some Thoughts for Design of Future Trials, 2013-07-19

• Virotherapy Using Myxoma Virus Prevents Lethal Graft-versus-Host Disease following Xeno-Transplantation with Primary Human Hematopoietic Stem Cells, 2012-08-14

• Myxoma Virus Targets Primary Human Leukemic Stem and Progenitor Cells While Sparing Normal Hematopoietic Stem and Progenitor Cells, 2009-10-29

• Vaccine Enthusiasm and Hesitancy in Cancer Patients and the Impact of a Webinar, 2021-03-19

• An Injectable Capillary-like Microstructured Alginate Hydrogel Improves Left Ventricular Function after Myocardial Infarction in Rats, 2016-06-25

• Infusion of alloanergized donor lymphocytes after CD34-selected haploidentical myeloablative hematopoietic stem cell transplantation, 2018-05-16

• Functional Genomic Landscape of Acute Myeloid Leukemia, 2018-10-17

• Building a precision oncology workforce by multidisciplinary and case-based learning, 2021-01-26

• Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD), 2016-08-26

• Interleukin-8 Blockade Prevents Activated Endothelial Cell Mediated Proliferation and Chemoresistance of Acute Myeloid Leukemia, 2019-07-03

• Effect of Intracoronary Delivery of Autolologous Bone Marrow Mononuclear Cells Two to Three Weeks Following Acute Myocardial Infarction on Left-Ventricular Function: The LateTIME Randomized Trial, 2011-11-14

• M6A demethylase ALKBH5 selectively promotes tumorigenesis and cancer stem cell self-renewal in acute myeloid leukemia, 2020-05-12

• Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System, 2022-01-29

• Diagnostic Testing, Treatment, Cost of Care, and Survival among Registered and Non-registered Patients with Myelodysplastic Syndromes, 2011-08-17

• Real-world diagnostic testing patterns for assessment of ring sideroblasts andSF3B1mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes, 2020-11-21

• Bone Marrow Cell Characteristics Associated with Patient Profile and Cardiac Performance Outcomes in the LateTIME-CCTRN Trial, 2016-07-06

• Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial, 2015-11-19

• Underreporting of Myeloid Malignancies by United States Cancer Registries, 2012-01-11

• The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells, 2006-02-16

• Implementation of Cancer Plans in the United States: A Review, 2021-03-07

• DNMT3A harboring leukemia-associated mutations directs sensitivity to DNA damage at replication forks, 2022-02-15

• Ex VivoVirotherapy With Myxoma Virus Does Not Impair Hematopoietic Stem and Progenitor Cells, 2016-01-15

• Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Ischemic Heart Failure: The FOCUS-CCTRN Trial, 2012-03-24

• Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect®MDS/AML Disease Registry, 2020-06-30

• Angiogenesis in Acute Myeloid Leukemia and Opportunities for Novel Therapies, 2011-09-05

• Response to Letter Regarding Article, "A Detailed Analysis of Bone Marrow from Patients with Ischemic Heart Disease and Left Ventricular Dysfunction: BM CD34, CD11b and Clonogenic Capacity as Biomarkers for Clinical Outcomes”, 2014-12-05

• Predicting response to BET inhibitors using computational modeling: A BEAT AML project study, 2019-01-07

• Selective purging of human multiple myeloma cells from autologous stem cell transplant grafts using oncolytic myxoma virus, 2012-04-16

• Post-hocAnalysis of Pharmacodynamics and Single-Agent Activity of CD3xCD123 Bispecific Antibody APVO436 in Relapsed/Refractory AML and MDS Resistant to HMA or Venetoclax Plus HMA, 2022-01-13

• Computational Modeling and Treatment Identification in the Myelodysplastic Syndromes, 2017-09-14

• Developing Mechanistic Insights into Cardiovascular Cell Therapy: Cardiovascular Cell Therapy Research Network (CCTRN) Biorepository Core Laboratory Rationale, 2011-11-29

• Identification of Unique mRNA and miRNA Expression Patterns in Bone Marrow Hematopoietic Stem and Progenitor Cells After Trauma in Older Adults, 2020-06-24

• Continuous Rural-Urban Coding for Cancer Disparity Studies: Is It Appropriate for Statistical Analysis?, 2019-03-26

• Functional Dependency Analysis Identifies Potential Druggable Targets in Acute Myeloid Leukemia, 2020-12-10

• Peripheral Blood Cytokine Levels After Acute Myocardial Infarction: IL-1ß and IL-6 Related Impairment of Bone Marrow Function, 2017-05-10

• Bone Marrow Characteristics Associated with Changes in Infarct Size after STEMI: A Biorepository Evaluation from the CCTRN TIME Trial, 2014-11-18